Your session is about to expire
← Back to Search
THC Testing for Cannabis Impairment (NHTSA-II Trial)
NHTSA-II Trial Summary
This trial will aim to increase understanding of how smoked cannabis affects cognition and driving ability, as well as how long these effects last. It will also look at how prior experience with cannabis use affects these abilities.
NHTSA-II Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowNHTSA-II Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2019 Phase 4 trial • 46 Patients • NCT03008005NHTSA-II Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- My high blood pressure is not under control.I am between 18 and 55 years old.I have a valid driver's license and over 2 years of driving experience.I have had a head injury that made me unconscious for more than 30 minutes or caused a concussion for 30 days.I do not have conditions like epilepsy that affect my brain function.I have a driver's license and over 2 years of driving experience.I have a history of serious illness, including cancer or neurological issues.I am between 18 and 55 years old.I have had bad reactions to cannabis in the past.You have recently used a medication called CNB and felt dizzy or high after taking it multiple times.
- Group 1: Placebo Marijuana
- Group 2: Medium THC Marijuana
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are youthful participants being accepted for the experiment?
"Participants must fall in the 18 to 55 year old demographic to be considered for this study. For those who are younger or older than that age bracket, there are various other trials available with different eligibility requirements."
To what degree could consuming Medium THC be detrimental to a patient's health?
"The minimal evidence regarding Medium THC's safety and efficacy leads to a score of 1."
What is the magnitude of people involved in this experiment?
"Affirmative. Clinicaltrials.gov data confirms that this medical experiment, which was originally posted on August 25th 2022, is currently recruiting participants. 32 individuals must be recruited from a single site for the trial's completion."
Is this experiment pioneering a new approach?
"Presently, 32 cities across 5 countries are hosting 31 distinct clinical trials for a pharmaceutical called 'Medium THC'. Jazz Pharmaceuticals initiated the first study of its kind in 2015 and it was composed of 200 patients. Since then, 60 such experiments have been concluded."
Are there any reports of previous research on the effects of Medium THC?
"Currently, 31 clinical trials involving Medium THC are actively running with 3 of them in their finale stage. Hartford Connecticut is the hub for many of these studies; however, there are 46 other locations that administer tests and collect data on this medication."
Is enrollment still available for this experiment?
"Indeed, the information hosted on clinicaltrials.gov denotes that this investigation is presently recruiting participants. This venture was initially posted on August 25th 2022 and has since been amended; 32 people are sought from a single location."
To what extent should certain individuals be targeted to enroll in this experiment?
"For acceptance into this trial, applicants should have a history of marijuana abuse and be between the ages of 18-55. This research project has 32 available slots in total."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
How responsive is this trial?
Typically responds via
Most responsive sites:
- Olin Neuropsychiatry Research Center: < 48 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger